Abbasi S, Dwaik H, Abbasi L, Al Hourani H. A pilot study of activity of pembrolizumab and low dose chemotherapy in relapsed/refractory T-cell lymphoma: Jordanian experience. Acta Biomed. 2024;95(5):e2024102. doi:10.23750/abm.v95i5.15559